Lacosamide Tablet, Film Coated
Product Images NDC 85742-009

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 85742-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kanchan Healthcare Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lac-12 (Lac 12)

This text provides a Kaplan-Meier analysis of the time to second generalized tonic-clonic seizure (2" PGTC Seizure) in Study 5. It mentions that the numbers at the bottom of the figure represent patients still at risk in the study at a specific timepoint, indicating the continuing patients without an event or censoring prior to that timepoint.*

FDA Label Image

Lacosamide-01 (Lacosamide 01)

FDA Label Image

Lacosamide-02 (Lacosamide 02)

FDA Label Image

Lacosamide-03 (Lacosamide 03)

The text provides information on responder rates for Lacosamide in comparison to a placebo in studies 2, 3, and 4. It includes the responder rate for Lacosamide at different doses (200mg/day, 400mg/day, 600mg/day) and the placebo group. This data is represented in Figure 2 showing the proportion of patients by responder rate.*

FDA Label Image

Lacosamide-04 (Lacosamide 04)

FDA Label Image

Lacosamide-05 (Lacosamide 05)

FDA Label Image

Lacosamide-06 (Lacosamide 06)

The text is not-readable.*

FDA Label Image

Lacosamide-07 (Lacosamide 07)

FDA Label Image

Lacosamide-08 (Lacosamide 08)

The text provides information about a medication containing 50 mg Lacosamide. It includes dosage and storage instructions, as well as details for pharmacists on dispensing the medication. The medication is manufactured in India by Medley Pharmaceuticals Ltd and is distributed in the USA. The dosage information and storage conditions are outlined in the text.*

FDA Label Image

Lacosamide-09 (Lacosamide 09)

FDA Label Image

Lacosamide-10 (Lacosamide 10)

This is a description of a medication called Lacosamide in the form of tablets. The package contains 60 tablets, each containing 150 mg of Lacosamide. The medication should be stored at 20° to 25°C (68 to 77°F), with excursions permitted between 15-30°C (59-86°F). The pharmacist is instructed to dispense the accompanying Medication Guide to each patient. The usual dosage information can be found in the package insert. The manufacturer's information is provided, with the manufacturing address in Daman and the distribution address in Parsippany, NJ, USA.*

FDA Label Image

Lacosamide-11 (Lacosamide 11)

This text indicates information about a medication named Lacosamide C in tablet form, with each tablet containing 200 mg of Lacosamide. It also provides dosage instructions and storage conditions. The medication is manufactured by Mediey Pharmaceuticals Ltd. in India and distributed by Kanchan Healthcare Inc. in the USA. It includes a statement about dispensing a Medication Guide to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.